当前位置: 首页 >> 检索结果
61. Exploring sleep health and circadian rhythm disruption in Sjögren's disease: an accelerometric and self-reported cross-sectional study.
作者: Caterina Di Pede.;Alessandro Colitta.;Simone Bruno.;Paolo Frumento.;Michelangelo Maestri Tassoni.;Giovanni Fulvio.;Gaetano La Rocca.;Enrica Bonanni.;Marta Mosca.;Rosaria Talarico.;Chiara Baldini.;Ugo Faraguna.
来源: Rheumatology (Oxford). 2026年
In a cross-sectional study, we aimed at characterizing possible impairments in sleep health and rest-activity parameters between patients with Sjögren's Disease (SjD) and healthy controls (HCs). Furthermore, we explored possible predictors of such disturbances in the SjD group.
62. Treatment satisfaction, disease severity, and health-care use in patients with axial spondyloarthritis in the United States and Europe.
作者: Elena Nikiphorou.;Alexis Ogdie.;Dan Twigg.;Emily Quiñones.;You-Li Ling.;Joseph C Cappelleri.;Lidia Sanchez-Riera.;Karim R Masri.;Megan Hughes.;Nicola Massey.
来源: Rheumatology (Oxford). 2026年65卷3期
The heterogeneous presentation of axial SpA (axSpA) complicates diagnosis and treatment decisions. This study compared patient symptoms, health-care resource utilization, and physician-patient alignment on disease severity and treatment satisfaction between the USA and five European countries (5EU).
65. Incident rheumatoid arthritis and work loss: a nationwide sibling comparison study.
作者: Heather Miller.;Gustaf Bruze.;Kari Johansson.;Johan Askling.;Martin Neovius.
来源: Rheumatology (Oxford). 2026年
Rheumatoid arthritis (RA) has been associated with substantial work loss, but advances in treatment have improved clinical outcomes for patients over time calling for an updated assessment. We therefore aimed to examine calendar trends in the association between RA diagnosis and work loss.
66. Clinical phenotype, MRI inflammatory involvement, and treatment patterns in HLA-B27 positive and negative axial spondyloarthritis: a Saudi MRI-based cohort study.
作者: Abdallah Alqethami.;Mohammed Basalama.;Samiyah Alsaedi.;Khulud Alqahtani.;Eman Alsindi.;Sabri Alsaeedi.;Roaa Mahroos.;Maysoon Taher.
来源: BMC Rheumatol. 2026年 67. Assessing disease activity in inflammatory arthritis using optical spectral transmission: a systematic review compared to joint ultrasound, MRI, and clinical activity markers.
作者: Ann-Kathrin Druck.;Chandana Keshavamurthy.;Mohammed Alhaddad.;Andreas V Goules.;Andreas Schwarting.;Konstantinos Triantafyllias.
来源: BMC Rheumatol. 2026年 69. Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.
作者: Laure Gossec.;Laura C Coates.;Robert B M Landewé.;Philip J Mease.;Joseph F Merola.;Christopher T Ritchlin.;Yoshiya Tanaka.;Akihiko Asahina.;Fabian Proft.;Nadine Goldammer.;Myriam Manente.;Barbara Ink.;Rajan Bajracharya.;Jason Coarse.;Iain B McInnes.
来源: Rheumatology (Oxford). 2026年
Bimekizumab, a monoclonal IgG1 antibody that selectively inhibits interleukin (IL)-17F in addition to IL-17A, has demonstrated tolerability and clinical efficacy in patients with psoriatic arthritis (PsA). Here, we report an additional year of safety and efficacy of bimekizumab to 3 years.
70. The impact of anti-SSA/Ro antibodies on pregnancy outcomes in patients with systemic lupus erythematosus.
作者: Eriho Yamaguchi.;Hideaki Tsuji.;Atsubumi Ogawa.;Yuto Nakakubo.;Takeshi Iwasaki.;Tomohiro Kozuki.;Tsuneyasu Yoshida.;Kunihiro Ichinose.;Takahisa Onishi.;Shigeru Ohno.;Hiroshi Kajiyama.;Takashi Kida.;Ken-Ei Sada.;Shuzo Sato.;Yasuhiro Shimojima.;Ayuko Takatani.;Keisuke Nishimura.;Michio Fujiwara.;Yusuke Matsuo.;Yoshia Miyawaki.;Ryo Yanai.;Ryusuke Yoshimi.;Akira Onishi.;Akio Morinobu.
来源: Rheumatology (Oxford). 2026年
We aimed to investigate the influence of anti-SSA/Ro antibodies and other factors on adverse pregnancy outcomes (APOs) in systemic lupus erythematosus (SLE) patients.
71. Nailfold capillaroscopy improves cardiovascular risk stratification in SSc: an adjustment of the SCORE2 algorithm.
作者: Carlos Valera-Ribera.;Juan José Alegre-Sancho.;Miguel Ángel González-Gay.;Joaquín Lacasa-Molina.;Alida Taberner-Cortés.;Montserrat Robustillo-Villarino.;Javier Narváez.
来源: Rheumatology (Oxford). 2026年65卷3期
SSc is characterized by micro- and macrovascular damage, increasing cardiovascular (CV) risk. The SCORE2 algorithm underestimates CV risk in systemic autoimmune diseases. Nailfold capillaroscopy (NFC) is used to assess SSc-related microvascular damage. We aimed to evaluate whether incorporating NFC findings into SCORE2/SCORE2-OP improves CV risk stratification in SSc.
72. Acute myocarditis after switching between two adalimumab biosimilars.
作者: Thomas Subervie.;François Sauer.;Jean-Jacques Von Hunolstein.;Eden Sebbag.;Etienne Dahan.;Wilhelm Storck.;Jacques Eric Gottenberg.;Jean Sibilia.;Marc Scherlinger.
来源: Rheumatology (Oxford). 2026年65卷3期 73. Segmental spinal damage predicts mobility restriction and functional decline in radiographic axial spondyloarthritis: a longitudinal study.
作者: Ismail Sari.;Seunghun Lee.;Sindhu R Johnson.;Robert D Inman.;Nigil Haroon.
来源: Rheumatology (Oxford). 2026年
To quantify the longitudinal association between radiographic spinal damage and spinal mobility and physical function in radiographic axial spondyloarthritis (r-axSpA) using discovertebral unit (DVU)-level analyses.
76. Anti CD19 targeting CAR T cell therapy in ANCA-associated vasculitis.
作者: Luisa Schneider.;Ann-Christin Pecher.;Luca Hensen.;Patrick Krumm.;Rebekka Schairer.;Kristina Reuß.;Wolfgang Bethge.;Claudia Lengerke.;Joerg Henes.
来源: Rheumatology (Oxford). 2026年65卷3期
To present a successful case study of anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in a patient with relapsing granulomatosis with polyangiitis (GPA).
78. Vaccination rates in rheumatic diseases: a cross-sectional register study on the role of patient beliefs and physician engagement.
作者: Samia Mehouachi.;Denis Mongin.;Gilles Eperon.;Delphine S Courvoisier.;Kim Lauper.
来源: Rheumatology (Oxford). 2026年
To evaluate the vaccination attitude and behaviour of patients with autoimmune inflammatory rheumatic diseases (AIIRD), and identify factors associated with vaccination status, utilising data from a national register.
79. B-cell monitoring predicts infection risk in childhood systemic lupus erythematosus patients on belimumab.
作者: Jingxiao Guo.;Yanjun Yang.;Lanlan Ge.;Peitong Han.;Fujuan Liu.;Meina Yin.
来源: Rheumatology (Oxford). 2026年
Belimumab improves outcomes in childhood-onset systemic lupus erythematosus (cSLE) but raises infection risks due to B cell modulation. We aimed to evaluate dynamic B cell and immunoglobulin G (IgG) monitoring for predicting infection risk.
|